|
Talavera, F; Bergman, C; Pearl, M L et al. (1995) cAMP and PMA enhance the effects of IGF-I in the proliferation of endometrial adenocarcinoma cell line HEC-1-A by acting at the G1 phase of the cell cycle. Cell Prolif 28:121-36
|
|
Gretz 3rd, H F; Talavera, F; Connor, P et al. (1994) Protein kinase C-dependent and -independent pathways mediate epidermal growth factor (EGF) effects in human endometrial adenocarcinoma cell line KLE. Gynecol Oncol 53:228-33
|
|
Pearl, M L; Talavera, F; Gretz 3rd, H F et al. (1993) Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC-1-A and KLE. Gynecol Oncol 49:325-32
|
|
Lelle, R J; Talavera, F; Gretz, H et al. (1993) Epidermal growth factor receptor expression in three different human endometrial cancer cell lines. Cancer 72:519-25
|
|
Ferreri, K; Talavera, F; Menon, K M (1992) Increased cellular cholesterol upregulates high density lipoprotein binding to rat luteal cells. Endocrinology 131:2059-64
|
|
Talavera, F; Menon, K M (1991) Studies on rat luteal cell response to insulin-like growth factor I (IGF-I): identification of a specific cell membrane receptor for IGF-I in the luteinized rat ovary. Endocrinology 129:1340-6
|
|
Talavera, F; Reynolds, R K; Roberts, J A et al. (1990) Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res 50:3019-24
|
